Ruslan Novo Pharmaceutical Private Limited, a active private limited company, was established on 01 November 2017 in Goregaon East, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2017PTC301377. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Harshika Dubey (Director), Amit Kumar Joshi (Director), Kavita Joshi (Director). Past directors included Harshika Dubey, Amit Kumar Joshi. It holds ₹0.75 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 119, 1St Floor Mastermind-V, Royal Palms, Aarey Milk Co, Lony, Goregaon East, Maharashtra, 400065.
U51909MH2017PTC301377
301377
01 November 2017
₹1.00 M
₹0.40 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ruslan Novo Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harshika Dubey | Director | 25 Jul 2023 | Current |
| Amit Kumar Joshi | Director | 16 Apr 2024 | Current |
| Kavita Joshi | Director | 01 Nov 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 07 Aug 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ruslan Novo Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.27% increase. The company also saw a substantial fall in profitability, with a 486.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ruslan Novo Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹750,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2022 | Bank Of India | ₹0.75 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ruslan Novo Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ruslan Novo Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruslan Novo Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ruslan Novo Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Amit Kumar Joshi was appointed as a Director was appointed as a Director on 16 Apr 2024 & has been associated with this company since 1 year 8 months . was completed.
Ruslan Novo Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Harshika Dubey was appointed as a Director was appointed as a Director on 25 Jul 2023 & has been associated with this company since 2 years 5 months . was completed.
A charge with Bank Of India amounted to Rs. 0.75 M with Charge ID 100588883 was registered on 17 Jun 2022. was recorded as a recent event.
The activity Kavita Joshi was appointed as a Director was appointed as a Director on 01 Nov 2017 & has been associated with this company since 8 years 1 month . was completed.
The CIN of Ruslan Novo Pharmaceutical Private Limited is U51909MH2017PTC301377.
Ruslan Novo Pharmaceutical Private Limited is headquartered at Office No. 119, 1St Floor Mastermind-V, Royal Palms, Aarey Milk Co, Lony, Goregaon East, Maharashtra, 400065.
Ruslan Novo Pharmaceutical Private Limited was incorporated on 01 November 2017.
The current directors of Ruslan Novo Pharmaceutical Private Limited are
The primary industry of Ruslan Novo Pharmaceutical Private Limited is Trade.
Ruslan Novo Pharmaceutical Private Limited is unlisted.
The authorized capital of Ruslan Novo Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
The compliance status of Ruslan Novo Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX